Evidence map›Paper›PMID 35268344›Full record

ArticleJournal of clinical medicine2022

Chronic Plaque Psoriasis in Poland: Disease Severity, Prevalence of Comorbidities, and Quality of Life.

Dorota Purzycka-Bohdan, Anna Kisielnicka, Monika Zabłotna, Bogusław Nedoszytko, Roman J Nowicki, Adam Reich, Dominik Samotij, Justyna Szczęch, Dorota Krasowska, Joanna Bartosińska and 14 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Impact ofJournal of clinical medicine · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 9 institutions in 1 country.

Dorota Purzycka-BohdanDepartment of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-210 Gdansk, Poland.ORCID 0000-0002-6089-8030
Anna KisielnickaDepartment of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-210 Gdansk, Poland.ORCID 0000-0001-8519-4892
Monika ZabłotnaDepartment of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-210 Gdansk, Poland.
Bogusław NedoszytkoDepartment of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-210 Gdansk, Poland.ORCID 0000-0002-6286-0693
Roman J NowickiDepartment of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-210 Gdansk, Poland.ORCID 0000-0003-4768-1387
Adam ReichDepartment of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.ORCID 0000-0002-5573-1754
Dominik SamotijDepartment of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.
Justyna SzczęchDepartment of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.ORCID 0000-0002-1524-2817
Dorota KrasowskaDepartment of Dermatology, Venerology and Paediatric Dermatology, Medical University of Lublin, 20-081 Lublin, Poland.ORCID 0000-0002-3176-9870
Joanna BartosińskaDepartment of Dermatology, Venerology and Paediatric Dermatology, Medical University of Lublin, 20-081 Lublin, Poland.ORCID 0000-0003-4106-3051
Joanna NarbuttDepartment of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, 90-419 Lodz, Poland.
Aleksandra LesiakDepartment of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, 90-419 Lodz, Poland.
Paulina BarasińskaDepartment of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, 90-419 Lodz, Poland.ORCID 0000-0001-6577-606X
Agnieszka Owczarczyk-SaczonekDepartment of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, Collegium Medicum, University of Warmia and Mazury, 10-229 Olsztyn, Poland.
Joanna CzerwińskaDepartment of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, Collegium Medicum, University of Warmia and Mazury, 10-229 Olsztyn, Poland.ORCID 0000-0001-6371-8130
Jacek C SzepietowskiDepartment of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-367 Wroclaw, Poland.ORCID 0000-0003-0766-6342
Aleksandra Batycka-BaranDepartment of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Rafał CzajkowskiDepartment of Dermatology and Venerology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland.ORCID 0000-0003-3418-1252
Magdalena Górecka-SokołowskaDepartment of Dermatology and Venerology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland.
Lidia RudnickaDepartment of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland.ORCID 0000-0002-8308-1023
Joanna CzuwaraDepartment of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland.
Marta Sobalska-KwapisBiobank Laboratory, Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland.
Dominik StrapagielBiobank Laboratory, Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland.ORCID 0000-0001-9752-4270
Aneta Szczerkowska-DoboszDepartment of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-210 Gdansk, Poland.
Gdańsk Medical University · PLMedical University of Lodz · PLUniversity of Rzeszów · PLMedical University of Lublin · PLMedical University of Warsaw · PLNicolaus Copernicus University · PLUniversity of Łódź · PLUniversity of Warmia and Mazury in Olsztyn · PLWroclaw Medical University · PL

Funding

The study was supported by funds from the Polish Ministry of Science and Higher Education 02-0066/07/253
6 · The paper itself

Abstract

The epidemiology of psoriasis has not been widely assessed in Polish population so far. This study aimed to investigate psoriasis epidemiological situation by evaluating disease course and severity, management, comorbidities, environmental factors, and knowledge about this disorder among psoriatic patients in Poland. A cross-sectional cohort population-based study enrolled 1080 psoriatic patients and 1200 controls. The mean age of psoriasis onset was 27.6 years; 78.24% had type I psoriasis. Positive family history of psoriasis was reported in 44.81% of patients, whereas itch was reported in vast majority of patients (83.33%). Based on PASI score moderate psoriasis was the most common in studied group (mean 12.63 ± 9.33, range 0−67.2). The DLQI score (12.01 ± 7.41, range 0−30.0) indicated a very large effect of psoriasis on the quality of life. Hypertension was the most prevalent comorbidity (33.80%), followed by obesity (16.85%) and dyslipidemia (11.85%). Stress was the foremost cause of disease exacerbation (66.20%); however, infections (44.07%) and seasonal changes (45.09%) had also an impact on the course of psoriasis. Psoriatic patients were more often smokers (37.59%) vs. general population (27.50%; p < 0.0001). In conclusion, epidemiological studies help clinicians in better disease and patient understanding, which may translate into better management and patient compliance.

Indexed as

comorbiditiesenvironmental factorsepidemiologypsoriasisquality of life

Identifiers

PMID35268344
PMCPMC8911198
OpenAlexW4214558513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.